SA
ARVN logo
Arvinas, Inc.(ARVN)
Closing price · checked 4:20 PM ETAbout this dataData status
$6.74▼-0.03 (-0.37%)
After Hours:$6.74+0.00 (+0.00%)· 4:20 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 29.1 · elevated volatility

Overview →

Consensus

Buy3.64 / 511 ratings · Buy 7 · Hold 4

Price vs analyst targets

Revenue and EPS estimates

ReportedConsensus estimates
Fiscal periodFY2023Dec '23FY2024Dec '24FY2025Dec '25FY2026Dec '26FY2027Dec '27FY2028Dec '28FY2029Dec '29FY2030Dec '30
Revenue (M)164.7263.4262.6277.547.861.794.7144.3
Growth YoY+33.0%+59.9%−0.3%+5.7%−82.8%+29.0%+53.5%+52.4%
High estimate–––328.1132.4106.5130.7199.2
Low estimate–––260.54.811.375.2114.7
Analysts–––10101055
EPS, adjusted−6.50−2.77−1.280.16−3.09−2.74−1.89−1.07
Growth YoYn/mn/mn/mn/m−2009.0%n/mn/mn/m
High estimate–––0.60−2.05−2.16−1.38−0.79
Low estimate–––−0.01−4.06−3.55−2.82−1.60
Analysts–––910855

Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.

Brokers

11 firms active in the last 12 months
FirmAnalystRatingPrev ratingTargetPrev targetChgUpsideDate
H.C. WainwrightAndrew FeinBuy · Nov 2026Buy$13.00$24.00−46%+93%Nov 4
Citigroup–BuyBuy––––Aug 10
Evercore ISI–OutperformOutperform$14.00––+108%Aug 10
Morgan Stanley–Equal Weight · May 2025Equal Weight$10.00$12.00−17%+48%Aug 10
WedbushRobert DriscollNeutralNeutral$12.00$11.00+9%+78%Aug 5
Wells Fargo–Equal WeightOverweight$11.00$26.00−58%+63%Aug 5
BTIG–BuyBuy$18.00$14.00+29%+167%Aug 4
Stephens & Co.–OverweightOverweight––––Jun 3
Barclays–OverweightOverweight$20.00$18.00+11%+197%May 13
Truist FinancialSrikripa DevarakondaHold · May 2025Buy$10.00$11.00−9%+48%Mar 18
Piper Sandler–OverweightOverweight––––Feb 25

Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.